AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

While many allergists were enthusiastic about the potential advantages of biologics compared with existing therapies to treat ...

The Holy City was the ninth worst in the U.S. for asthma patients, according to a new ranking from the Asthma and Allergy Foundation ... University of South Carolina, who is Alderman's doctor.

Vexed by taunts about his own medical situation, former President Donald Trump warned Tuesday that Vice President Kamala ...

One in three adults has a seasonal allergy in the United States, according to the National Institutes of Health. To make ...

Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.

The BATURA data will be presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting on October 26, 2024. Albuterol/budesonide is also currently being ...

Kansas City was named the 20th worst city to live with pollen allergies in 2024, according to an analysis by the Asthma and Allergy Foundation ... in South Carolina, and at KCUR.

These DIY kits are a $5 billion industry. We report on the pros, the cons, and the ones to avoid at all costs.

according to the American College of Allergy Asthma and Immunology. Because of the risk, announcements like this one are ...